Sechenov School
Home › Pathology › Neuroblastoma

Neuroblastoma

Neuroblastoma

For medical students2 min readUpdated 2026-10-10

Neuroblastoma is a malignant solid pediatric tumor arising from neural crest cells. It most commonly localizes to the adrenal medulla and sympathetic ganglia, possessing a unique capacity for spontaneous regression or maturation into a benign form.

HistogenesisNeural crest cells
LocalizationAdrenal medulla and sympathetic ganglia (up to 40%)
Mean age2 years (85–90% of patients under 5 years old)
Incidence6–8 cases per 1 million children (14% of all pediatric tumors)

Epidemiology and Risk Factors

Neuroblastoma is the third most common solid tumor in children, developing outside the central nervous system. It occurs slightly less frequently in females than in males, though females tend to have a more favorable prognosis.

The etiology is rooted in a hereditary predisposition, hypothesized to involve germline mutations that render cells susceptible to secondary somatic mutations.

Risk Factors and Associations:

Gross Pathology

The tumor forms a mass of varying size, which on cross-section appears as soft, grayish tissue resembling brain parenchyma. Large masses frequently undergo secondary changes that create a heterogeneous structure, including foci of necrosis, hemorrhage, and calcification.

Relationship to Surrounding Tissues:

Microscopic Structure and Differentiation

The histological appearance of neuroblastoma directly depends on its degree of maturity. The tumor is prone to heterogeneity; a single mass may contain areas of varying differentiation.

  1. Poorly differentiated neuroblastoma (constitutes the majority of cases). Composed of small, lymphocyte-like cells with dark (hyperchromatic) nuclei and scanty cytoplasm. Cells form solid, contiguous sheets.
  2. More differentiated tumors. Cells acquire eosinophilic neurofibrillar processes and are arranged within an increasing volume of fibrillary stroma. The appearance of Homer Wright pseudorosettes is characteristic—structures where cells form a ring around central eosinophilic clusters of neurofibrils.
  3. Ganglioneuroma. Represents a terminally differentiated tumor. Composed of large, mature ganglion cells (with broad eosinophilic cytoplasm, large vesicular nuclei, and distinct nucleoli). The cells are surrounded by bundles of connective tissue, nerve fibers, and Schwann cells (lemmocytes).

Transmission electron microscopy reveals specific markers in neuroblastoma cells: neurosecretory granules and processes containing microtubules.

International Staging System

Staging is performed based on the pathological examination of surgically resected material:

Mnemonic

To remember Stage 4S, associate the letter 'S' with 'Small' patient (the stage occurs exclusively in infants under 1 year). Despite distant metastasis (skin, liver, bone marrow), the primary tumor remains localized (Stage 1 or 2).

Frequently asked questions

What biochemical markers (catecholamine metabolites) are measured in urine to diagnose neuroblastoma?

The diagnosis of neuroblastoma involves measuring the following biochemical markers and catecholamine metabolites in the urine:

  • Vanillylmandelic acid (VMA) — a catecholamine metabolite.
  • Homovanillic acid (HVA) — a catecholamine metabolite.
  • Norepinephrine — a catecholamine.
  • Dopamine — a catecholamine.

Elevated urinary concentrations of these substances are observed in approximately 90% of patients with neuroblastoma, serving as an important diagnostic criterion.

Amplification of which oncogene is the most critical unfavorable prognostic factor in neuroblastoma?

An important adverse prognostic factor in neuroblastoma is amplification of the N-myc (MYCN) oncogene.

Increased copy number of N-myc in neuroblastoma correlates with a poor prognosis; it is detected in about 38% of cases. In disseminated disease, up to 300 copies of N-myc may be found, which is uncharacteristic of a benign clinical course. Both gene amplification and expression levels hold prognostic significance.

To which organs and tissues (besides the liver and skin) does Stage 4 neuroblastoma most frequently metastasize hematogenously?

In addition to the liver and skin, Stage 4 neuroblastoma most frequently metastasizes hematogenously to the bone marrow and bones (skeleton).

  • Bone marrow — a typical site of involvement, which is also characteristic of the specific Stage 4S in infants under 1 year.
  • Bones — a frequent site of metastasis, causing bone and joint pain.

Less commonly, hematogenous metastasis may affect the lungs and brain. Stage 4 is also characterized by metastasis to distant lymph nodes.

What are pseudorosettes and what are they characteristic of?

These are specific microscopic structures in which tumor cells form a wreath around a central cluster of eosinophilic neurofibrils. They are characteristic of differentiating neuroblastomas.

Why does a diagnosis of ganglioneuroma require examination of multiple histological sections?

Neuroblastomas often have a heterogeneous structure. To establish a diagnosis of benign ganglioneuroma, one must rule out the presence of poorly differentiated malignant areas by examining material from various zones of the tumor mass.

What favorable outcomes are possible in neuroblastoma?

Neuroblastoma is characterized by two unique outcomes: spontaneous regression (especially in small-sized tumors) and maturation of tumor cells into a benign ganglioneuroma.

Go deeper

More topics in Pathology

Megaloblastic AnemiasChemical and Physical CarcinogenesisDemyelinating Diseases and CNS InfectionsGestational Trophoblastic DiseaseBlistering Skin Conditions and Epidermal PathologiesPertussisApical PeriodontitisPeriodontal DiseasesMesenchymal Protein DystrophiesMicroscopic Features of NecrosisMechanisms of Adaptation and CompensationSystemic Effects of InflammationPathology →